Thomas Edward Gibbs
Corporate Officer/Principal bei H. LUNDBECK A/S
Profil
Thomas Edward Gibbs is currently the Director at Sunovion Pharmaceuticals Europe Ltd.
and the Executive Vice President & Head-United States at H.
Lundbeck A.
Previously, he served as the Chief Executive Officer & Global Business Leader at Vectura, Inc. He completed his undergraduate degree at the University of Pennsylvania and holds an MBA from The Wharton School of the University of Pennsylvania.
Aktive Positionen von Thomas Edward Gibbs
| Unternehmen | Position | Beginn |
|---|---|---|
| H. LUNDBECK A/S | Corporate Officer/Principal | 28.02.2023 |
Sunovion Pharmaceuticals Europe Ltd.
 Sunovion Pharmaceuticals Europe Ltd. Pharmaceuticals: MajorHealth Technology Sunovion Pharmaceuticals Europe Ltd. is a British European pharmaceutical company founded in 2013 that is dedicated to improving the lives of patients through the supply of essential medicines. The company is based in London, UK. The company commercializes and distributes a portfolio of specialty brands and hospital products in 40 countries worldwide, both directly and through strategic partnerships. The company's vision is to become a recognized partner of choice through their commercial excellence, patient focus, and presence across the globe. Sunovion Pharmaceuticals Europe aims to have a positive impact on society through their pioneering focus on their environment, social, and governance (ESG) goals. | Direktor/Vorstandsmitglied | 05.12.2019 |
Ehemalige bekannte Positionen von Thomas Edward Gibbs
| Unternehmen | Position | Ende |
|---|---|---|
Vectura, Inc.
 Vectura, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Philip Morris International, Inc., Vectura, Inc. provides consulting services to the pharmaceutical industry. | Vorstandsvorsitzender | - |
Ausbildung von Thomas Edward Gibbs
| University of Pennsylvania | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| H. LUNDBECK A/S | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Sunovion Pharmaceuticals Europe Ltd.
Sunovion Pharmaceuticals Europe Ltd. Pharmaceuticals: MajorHealth Technology Sunovion Pharmaceuticals Europe Ltd. is a British European pharmaceutical company founded in 2013 that is dedicated to improving the lives of patients through the supply of essential medicines. The company is based in London, UK. The company commercializes and distributes a portfolio of specialty brands and hospital products in 40 countries worldwide, both directly and through strategic partnerships. The company's vision is to become a recognized partner of choice through their commercial excellence, patient focus, and presence across the globe. Sunovion Pharmaceuticals Europe aims to have a positive impact on society through their pioneering focus on their environment, social, and governance (ESG) goals. | Health Technology |
Vectura, Inc.
Vectura, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Philip Morris International, Inc., Vectura, Inc. provides consulting services to the pharmaceutical industry. | Commercial Services |
